Own a Part of the Fastest-Growing Psychedelic Care Platform

News provided by

Oct 24, 2023, 08:44 ET

Choose Your Horizon Launches a New Crowdfunding Campaign on StartEngine That's Open to All Investors

AUSTIN, Texas, Oct. 24, 2023 /PRNewswire/ -- Choose Your Horizon is at the forefront of the psychedelic therapy movement that promises to transform how we treat mental health conditions and dramatically improve quality of life for millions of people.

Invest in Choose Your Horizon With StartEngine

At-Home Ketamine Therapy From Choose Your Horizon

Established in 2021, the Choose Your Horizon wellness platform brings telemedicine and ketamine therapy together to provide more people with access to the care they so urgently need. In a short period, Choose Your Horizon has experienced an impressive level of growth. Already this year, the company has expanded its market area to 15 states with plans to enter five more states by the end of 2023.

"Our mission is to make affordable and responsible psychedelic therapy available to all," says CEO and co-founder Mark Holland. "Our business has grown 10X in 2023 over 2022 and we are realizing our goal of completely democratizing access to this transformative therapy. Now we're giving all investors the ability to own a part of this journey."

Choose Your Horizon is excited to announce the launch of a StartEngine crowdfunding campaign as it continues to expand across the U.S. helping millions more people who are suffering from depression, anxiety and PTSD. Investors can get in at the ground floor to become a part of this exciting movement towards improved mental health care.

Reasons to invest in Choose Your Horizon include:

-Rapid expansion. Choose Your Horizon has $1.7M+ sales Y2D for 2023 across 15 states. The company is actively expanding and is on track to offer at-home ketamine therapy in 20 states by EOY 2023 with the goal of serving all 50 states by the end of 2024.

-Real world results. Choose Your Horizon is already saving lives and improving quality of life by connecting thousands of people to medical advisors that are skilled in psychedelic medicine and psychiatry. Already over 1,400 patients have been helped with 98% seeing improvements in their symptoms and less than 1% experiencing adverse side effects.

-Huge growth potential in three promising markets. Choose Your Horizon sits at the rapidly growing intersection of telemedicine $106Bn (24% CAGR), the $3.1B ketamine therapy market (10.6% CAGR growth) and $4.8B psychedelics market (12.49% CAGR growth). The company's telemedicine model allows for accessibility and a gross margin rate of approximately 70%.

-Co-founders with a profitable track record in healthcare. Choose Your Horizon's co-founders have had two successful healthcare exits that exceeded $100 million.

All interested investors can visit the Choose Your Horizon StartEngine campaign page to learn more about being part of the movement that's transforming how mental health disorders are treated.

About Choose Your Horizon Inc.
Choose Your Horizon is a mental wellness platform that's making affordable access to ketamine therapy possible across the U.S. The company is dedicated to developing highly therapeutic customer journeys and patient protocols. In addition to oral ketamine assisted therapy experiences, Choose is working with novel sound and light therapies that have the potential to improve the ketamine assisted therapy experience and patient outcomes.

Media Contact:
Rob Lee
202-963-1356
[email protected]

SOURCE Choose Your Horizon